Cargando…

Clinical outcomes of transcatheter aortic valve replacement stratified by left ventricular ejection fraction: A single centre pilot study

INTRODUCTION: To define baseline echocardiographic, electrocardiographic (ECG) and computed tomographic (CT) findings of patients with heart failure undergoing transcatheter aortic valve replacement (TAVR) and analyze their overall procedural outcomes. METHODS: Between 2018 and 2021, patients with s...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Balool, Joud, Al Jarallah, Mohammed, Rajan, Rajesh, Dashti, Raja, Alasousi, Nader, Kotevski, Vladimir, Taha Mousa, Ahmed Said, Al Haroun, Retaj, Tse, Gary, Zhanna, Kobalava D., Setiya, Parul, Saber, Ahmad Al, Brady, Peter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142703/
https://www.ncbi.nlm.nih.gov/pubmed/35638043
http://dx.doi.org/10.1016/j.amsu.2022.103712
_version_ 1784715632429760512
author Al Balool, Joud
Al Jarallah, Mohammed
Rajan, Rajesh
Dashti, Raja
Alasousi, Nader
Kotevski, Vladimir
Taha Mousa, Ahmed Said
Al Haroun, Retaj
Tse, Gary
Zhanna, Kobalava D.
Setiya, Parul
Saber, Ahmad Al
Brady, Peter A.
author_facet Al Balool, Joud
Al Jarallah, Mohammed
Rajan, Rajesh
Dashti, Raja
Alasousi, Nader
Kotevski, Vladimir
Taha Mousa, Ahmed Said
Al Haroun, Retaj
Tse, Gary
Zhanna, Kobalava D.
Setiya, Parul
Saber, Ahmad Al
Brady, Peter A.
author_sort Al Balool, Joud
collection PubMed
description INTRODUCTION: To define baseline echocardiographic, electrocardiographic (ECG) and computed tomographic (CT) findings of patients with heart failure undergoing transcatheter aortic valve replacement (TAVR) and analyze their overall procedural outcomes. METHODS: Between 2018 and 2021, patients with severe aortic stenosis (AS) who performed transcatheter aortic valve replacement (TAVR) in Sabah Al Ahmad Cardiac Centre, Al Amiri Hospital were identified. A retrospective review of patients' parameters including pre-, intra-, and post-procedural data was conducted. Patients were grouped in 2 subgroups according to their EF: EF <40% (HFrEF) and EF ≥ 40%. The data included patients’ baseline characteristics, electrocardiographic and echocardiographic details along with pre-procedural CT assessment of aortic valve dimensions. Primary outcomes including post-operative disturbances, pacemaker implantation and in-hospital mortality following TAVR were additionally analyzed. RESULTS: A total of 61 patients with severe AS underwent TAVR. The mean age was 73.5 ± 9, and 21 (34%) of the patients were males. The mean ejection fraction (EF) was 55.5 ± 9.7%. Of 61 patients, 12 (20%) were identified as heart failure with reduced EF (<40%). These patients were younger, more often males, and were more likely to have coronary artery disease (75% versus 53.1%). Left ventricular hypertrophy and diastolic dysfunction was documented in 75% and 58.3% of patients with heart failure with reduced ejection fraction (HFrEF) respectively. Post TAVR conduction disturbances, with the commonest being LBBB was observed in 41.7%. Permanent pacemaker was implanted in 3 of patients with HFrEF (25%). There were no significant differences between the two groups with regards to in hospital mortality (p = 0.618). CONCLUSION: Severe AS with EF <40% constitute a remarkable proportion of patients undergoing TAVR. Preliminary results of post-operative conduction disturbances and in hospital mortality in HFrEF patients were concluded to not differ from patients with LVEF ≥40%.
format Online
Article
Text
id pubmed-9142703
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91427032022-05-29 Clinical outcomes of transcatheter aortic valve replacement stratified by left ventricular ejection fraction: A single centre pilot study Al Balool, Joud Al Jarallah, Mohammed Rajan, Rajesh Dashti, Raja Alasousi, Nader Kotevski, Vladimir Taha Mousa, Ahmed Said Al Haroun, Retaj Tse, Gary Zhanna, Kobalava D. Setiya, Parul Saber, Ahmad Al Brady, Peter A. Ann Med Surg (Lond) Policy Review INTRODUCTION: To define baseline echocardiographic, electrocardiographic (ECG) and computed tomographic (CT) findings of patients with heart failure undergoing transcatheter aortic valve replacement (TAVR) and analyze their overall procedural outcomes. METHODS: Between 2018 and 2021, patients with severe aortic stenosis (AS) who performed transcatheter aortic valve replacement (TAVR) in Sabah Al Ahmad Cardiac Centre, Al Amiri Hospital were identified. A retrospective review of patients' parameters including pre-, intra-, and post-procedural data was conducted. Patients were grouped in 2 subgroups according to their EF: EF <40% (HFrEF) and EF ≥ 40%. The data included patients’ baseline characteristics, electrocardiographic and echocardiographic details along with pre-procedural CT assessment of aortic valve dimensions. Primary outcomes including post-operative disturbances, pacemaker implantation and in-hospital mortality following TAVR were additionally analyzed. RESULTS: A total of 61 patients with severe AS underwent TAVR. The mean age was 73.5 ± 9, and 21 (34%) of the patients were males. The mean ejection fraction (EF) was 55.5 ± 9.7%. Of 61 patients, 12 (20%) were identified as heart failure with reduced EF (<40%). These patients were younger, more often males, and were more likely to have coronary artery disease (75% versus 53.1%). Left ventricular hypertrophy and diastolic dysfunction was documented in 75% and 58.3% of patients with heart failure with reduced ejection fraction (HFrEF) respectively. Post TAVR conduction disturbances, with the commonest being LBBB was observed in 41.7%. Permanent pacemaker was implanted in 3 of patients with HFrEF (25%). There were no significant differences between the two groups with regards to in hospital mortality (p = 0.618). CONCLUSION: Severe AS with EF <40% constitute a remarkable proportion of patients undergoing TAVR. Preliminary results of post-operative conduction disturbances and in hospital mortality in HFrEF patients were concluded to not differ from patients with LVEF ≥40%. Elsevier 2022-05-07 /pmc/articles/PMC9142703/ /pubmed/35638043 http://dx.doi.org/10.1016/j.amsu.2022.103712 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Policy Review
Al Balool, Joud
Al Jarallah, Mohammed
Rajan, Rajesh
Dashti, Raja
Alasousi, Nader
Kotevski, Vladimir
Taha Mousa, Ahmed Said
Al Haroun, Retaj
Tse, Gary
Zhanna, Kobalava D.
Setiya, Parul
Saber, Ahmad Al
Brady, Peter A.
Clinical outcomes of transcatheter aortic valve replacement stratified by left ventricular ejection fraction: A single centre pilot study
title Clinical outcomes of transcatheter aortic valve replacement stratified by left ventricular ejection fraction: A single centre pilot study
title_full Clinical outcomes of transcatheter aortic valve replacement stratified by left ventricular ejection fraction: A single centre pilot study
title_fullStr Clinical outcomes of transcatheter aortic valve replacement stratified by left ventricular ejection fraction: A single centre pilot study
title_full_unstemmed Clinical outcomes of transcatheter aortic valve replacement stratified by left ventricular ejection fraction: A single centre pilot study
title_short Clinical outcomes of transcatheter aortic valve replacement stratified by left ventricular ejection fraction: A single centre pilot study
title_sort clinical outcomes of transcatheter aortic valve replacement stratified by left ventricular ejection fraction: a single centre pilot study
topic Policy Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142703/
https://www.ncbi.nlm.nih.gov/pubmed/35638043
http://dx.doi.org/10.1016/j.amsu.2022.103712
work_keys_str_mv AT albalooljoud clinicaloutcomesoftranscatheteraorticvalvereplacementstratifiedbyleftventricularejectionfractionasinglecentrepilotstudy
AT aljarallahmohammed clinicaloutcomesoftranscatheteraorticvalvereplacementstratifiedbyleftventricularejectionfractionasinglecentrepilotstudy
AT rajanrajesh clinicaloutcomesoftranscatheteraorticvalvereplacementstratifiedbyleftventricularejectionfractionasinglecentrepilotstudy
AT dashtiraja clinicaloutcomesoftranscatheteraorticvalvereplacementstratifiedbyleftventricularejectionfractionasinglecentrepilotstudy
AT alasousinader clinicaloutcomesoftranscatheteraorticvalvereplacementstratifiedbyleftventricularejectionfractionasinglecentrepilotstudy
AT kotevskivladimir clinicaloutcomesoftranscatheteraorticvalvereplacementstratifiedbyleftventricularejectionfractionasinglecentrepilotstudy
AT tahamousaahmedsaid clinicaloutcomesoftranscatheteraorticvalvereplacementstratifiedbyleftventricularejectionfractionasinglecentrepilotstudy
AT alharounretaj clinicaloutcomesoftranscatheteraorticvalvereplacementstratifiedbyleftventricularejectionfractionasinglecentrepilotstudy
AT tsegary clinicaloutcomesoftranscatheteraorticvalvereplacementstratifiedbyleftventricularejectionfractionasinglecentrepilotstudy
AT zhannakobalavad clinicaloutcomesoftranscatheteraorticvalvereplacementstratifiedbyleftventricularejectionfractionasinglecentrepilotstudy
AT setiyaparul clinicaloutcomesoftranscatheteraorticvalvereplacementstratifiedbyleftventricularejectionfractionasinglecentrepilotstudy
AT saberahmadal clinicaloutcomesoftranscatheteraorticvalvereplacementstratifiedbyleftventricularejectionfractionasinglecentrepilotstudy
AT bradypetera clinicaloutcomesoftranscatheteraorticvalvereplacementstratifiedbyleftventricularejectionfractionasinglecentrepilotstudy